Avantor, Inc. (AVTR)

9.26 0.21 (2.32%)

As of 2026-02-17 18:36:24 EST

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.

Traded asNYSE: AVTR
ISINUS05352A1007
CIK0001722482
LEI—
EIN822758923
SectorPharmaceuticals
IndustryLaboratory Analytical Instruments
CEOEmmanuel Ligner
Employees14,500
Fiscal Year End1231
AddressRADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087
Phone(610) 386-1700
Websitehttp://avantorsciences.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
AVTRAvantor, Inc.2026-02-17 18:36:249.260.212.32
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
AVTR0001722482Avantor, Inc.US05352A1007—822758923NYSE3826Laboratory Analytical Instruments1231—RADNOR CORPORATE CENTER, BUILDING ONERADNORPA19087UNITED STATESUS(610) 386-1700RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087Vail Holdco CorpPharmaceuticals1904Emmanuel Ligner14,500http://avantorsciences.com9,173,395,483682,000,000682,055,932Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.2026-02-12 16:19:19
This is a preview of the latest data. Subscribe to access the full data.
AVTR Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
AVTR Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20259,173,395,483-5,234,384,175-36.3303682,055,9321,153,3600.1694
202414,407,779,658529,866,2573.8181680,902,5722,621,1890.3864
202313,877,913,401-7,081,445,257-33.7866678,281,3833,837,8770.569
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Randy StoneExecutive Vice President2023415,38502,105,34234,19233,2004,588,116
Frederic VanderhaegenExecutive Vice President2023618,21201,749,55952,761122,8953,043,353
Michael StubblefieldChief Executive Officer, Director, President20231,140,00008,529,219188,10036,50012,338,767
R. Brent JonesChief Financial Officer, Executive Vice President2023221,154200,0002,817,99818,52622,0155,840,795
James BramwellExecutive Vice President2023497,98101,749,55939,38433,6502,840,235
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202513,500
202413,500
202314,500
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue6,552,200,0006,783,600,0006,967,200,000
Cost Of Revenue4,412,800,0004,504,300,0004,603,400,000
Gross Profit2,139,400,0002,279,300,0002,363,800,000
Research And Development Expenses———
General And Administrative Expenses1,595,500,0001,641,100,0001,506,600,000
Operating Expenses———
Operating Income-246,200,0001,084,800,000696,400,000
Net Income-530,200,000711,500,000321,100,000
Earnings Per Share Basic-0.781.050.48
Earnings Per Share Diluted-0.781.040.47
Weighted Average Shares Outstanding Basic680,600,000679,600,000675,600,000
Weighted Average Shares Outstanding Diluted680,600,000681,900,000678,400,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents365,400,000261,900,000262,900,000
Marketable Securities Current———
Accounts Receivable1,074,600,0001,034,500,0001,150,200,000
Inventories818,200,000731,500,000828,100,000
Non Trade Receivables———
Other Assets Current193,000,000118,700,000143,700,000
Total Assets Current2,451,200,0002,146,600,0002,384,900,000
Marketable Securities Non Current———
Property Plant And Equipment766,800,000708,100,000737,500,000
Other Assets Non Current396,000,000360,400,000358,300,000
Total Assets Non Current9,343,500,0009,967,900,00010,587,800,000
Total Assets11,794,700,00012,114,500,00012,972,700,000
Accounts Payable741,700,000662,800,000625,900,000
Deferred Revenue———
Short Term Debt30,800,000821,100,000259,900,000
Other Liabilities Current396,400,000306,800,000411,200,000
Total Liabilities Current1,378,900,0002,007,500,0001,480,300,000
Long Term Debt3,946,300,0004,055,800,0005,536,600,000
Other Liabilities Non Current378,200,000358,300,000350,300,000
Total Liabilities Non Current4,850,800,0004,150,300,0006,239,800,000
Total Liabilities6,229,700,0006,157,800,0007,720,100,000
Common Stock3,984,800,0003,937,700,0003,830,100,000
Retained Earnings1,672,800,0002,203,000,0001,491,500,000
Accumulated Other Comprehensive Income-16,900,000-184,000,000-69,000,000
Total Shareholders Equity5,565,000,0005,956,700,0005,252,600,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization301,100,000299,800,000402,300,000
Share Based Compensation Expense46,400,00046,800,00040,500,000
Other Non Cash Income Expense1,300,000300,000700,000
Change In Accounts Receivable-13,600,000-45,900,000-77,000,000
Change In Inventories109,400,00018,500,000-30,300,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable42,400,00059,600,000-139,600,000
Change In Other Liabilities144,200,00037,700,000-48,600,000
Cash From Operating Activities623,800,000840,800,000870,000,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment128,800,000148,800,000146,400,000
Acquisition Of Business—00
Other Investing Activities1,700,000-2,500,000-2,700,000
Cash From Investing Activities-130,500,000438,900,000-143,700,000
Tax Withholding For Share Based Compensation5,600,000——
Payments Of Dividends———
Issuance Of Common Stock——0
Repurchase Of Common Stock75,100,000——
Issuance Of Long Term Debt1,107,600,00000
Repayment Of Long Term Debt1,426,300,0001,341,800,000846,000,000
Other Financing Activities5,100,000-8,600,000-13,700,000
Cash From Financing Activities-409,400,000-1,281,200,000-843,700,000
Change In Cash103,600,000-23,000,000-109,200,000
Cash At End Of Period365,400,000261,900,000262,900,000
Income Taxes Paid145,000,000247,800,000224,400,000
Interest Paid161,300,000211,000,000267,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-0.781.050.48
Price To Earnings Ratio-14.692320.066747.5625
Earnings Growth Rate-174.2857118.75-52.9412
Price Earnings To Growth Ratio0.08430.169-0.8984
Book Value Per Share8.17668.7657.7747
Price To Book Ratio1.40162.40392.9364
Ebitda85,700,0001,477,900,0001,232,600,000
Enterprise Value11,411,376,00018,934,172,00020,957,548,000
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.71470.81871.1035
Capital Expenditures359,800,000270,400,000412,800,000
Free Cash Flow264,000,000570,400,000457,200,000
Return On Equity-0.09530.11940.0611
One Year Beta1.10860.80670.8376
Three Year Beta0.97260.9290.9695
Five Year Beta0.9851.04911.0658
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
SUMME GREGORY LDirector2026-02-12100,000A400,000
Dingemans SimonDirector2026-01-026,225A6,225
MEHRA SANJEEV KDirector2025-12-058,106A8,106
MEHRA SANJEEV KDirector2025-12-05350,000A350,000
Ligner EmmanuelDirector, President and CEO2025-11-1787,500A283,424
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Gilbert Cisneros2025-09-12CA31Sale2025-08-13—$1,001 - $15,000
Gilbert Cisneros2025-09-12CA31Sale (Partial)2025-08-12—$1,001 - $15,000
Gilbert Cisneros2025-08-14CA31Sale (Partial)2025-07-23—$1,001 - $15,000
Lisa McClain2025-08-13MI09Purchase2025-06-11Spouse$1,001 - $15,000
Lisa McClain2025-08-13MI09Sale (Partial)2025-06-17Spouse$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Cetera Investment Advisers2025-12-31329,70328,77011.46
Freestone Grove Partners LP2025-12-3129,612,7092,584,00611.46
GUGGENHEIM CAPITAL LLC2025-12-31174,66215,24111.46
ADAR1 Capital Management, LLC2025-12-31802,20070,00011.46
AQR CAPITAL MANAGEMENT LLC2025-12-3150,327,7004,391,59711.46
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
EMPOWER FUNDS, INC.2025-12-31Institutional ClassMXUGX33,00031,556.420.0023
EMPOWER FUNDS, INC.2025-12-31Institutional ClassMXUGX325,000323,234.130.0233
EMPOWER FUNDS, INC.2025-12-31Investor ClassMXLMX33,00031,556.420.0023
EMPOWER FUNDS, INC.2025-12-31Investor ClassMXLMX325,000323,234.130.0233
EMPOWER FUNDS, INC.2025-12-31Institutional ClassMXYKX1,213,20013,903,272.030.6911
This is a preview of the latest data. Subscribe to access the full data.